News

Bendit Announces FDA Clearance for the Bendit17™ Steerable Microcatheter

TEL AVIV, Israel, Dec. 10, 2025 /PRNewswire/ -- Bendit Technologies is proud to announce that the U.S. Food and Drug…

2 weeks ago

Zocdoc Reveals Evolving Patient Preferences and Trends in Third Annual What Patients Want Report

This 2025 deep dive into patient preferences—derived from millions of Zocdoc bookings across states, specialties, and insurance plans—shows patients want…

2 weeks ago

Sinceri Senior Living Expands Texas Presence Through New Partnership with CareTrust REIT

HOUSTON, TEXAS / ACCESS Newswire / December 10, 2025 / Sinceri Senior Living is pleased to announce the addition of…

2 weeks ago

Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Real Game Used Achieves Major Milestone in High-End Memorabilia Authentication

With AI-based pattern recognition and game-used wear detection, Real Game Used is pioneering the future of authentication. MESA, ARIZONA /…

2 weeks ago

Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /…

2 weeks ago

Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /…

2 weeks ago

Sant’ Andrea University Hospital to Integrate GE HealthCare and Tribun Health’s Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care

GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire /…

2 weeks ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 weeks ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 weeks ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

Conditional approval extended through December 2026 for the treatment of CID in dogsCID confirmatory effectiveness trial expected to conclude in…

2 weeks ago